Literature DB >> 34274783

Effect of healthcare system reforms on public hospitals' revenue structures: Evidence from Beijing, China.

Lu Gao1, Leiyu Shi2, Qingyue Meng3, Xiangrong Kong4, Moning Guo5, Feng Lu5.   

Abstract

To reduce the heavy reliance of public hospitals on drug sales and use of advanced technologies and to contain the escalating medical expenditures, Beijing implemented two rounds of comprehensive public hospital reform in 2017 and 2019, respectively. The first round focused on separating drug sales from hospital revenue (reform1), and the second round extended to include zero markup on medical consumables and price adjustments for medical services (reform2). To estimate how these two rounds of reform have affected public hospitals' revenue structures, we used observational data of medical revenues from 2016 to 2019 covering 354 healthcare facilities. A Panel-interrupted time-series (PITS) model was used to analyze the effects. The results suggest that the reforms have changed the structure of public hospitals' revenues. The proportion of drug sales in hospital revenues fell from 43.96% in 2016 (pre-reform) to 34.08% in 2019 (post-reform); the proportions of medical consumables decreased by 0.73% after reform 2; and the proportion of medical consultation service fees increased from 15.16% in 2016 to 24.51% in 2019. PITS analysis showed that the proportion of drug sales dropped by 5.46% in the month of reform 1, and it dropped by 0.20% per month on average after reform 2(p < 0.001). The proportion of medical consumables decreased by 0.04% per month on average after reform 2 (p < 0.001). The proportion of medical consultation service increased by 7.13% in the month of reform 1, and it increased by 0.14% per month on average after reform 2(p < 0.001). Similar trends were seen in hospital revenue structures from both inpatient services and from outpatient and accident and emergency services. Thus, Beijing's reforms successfully contained rising medical expenditures and optimized hospitals' revenue structures. These reforms can provide a reference for further public hospital reforms in China and other countries with similar systems.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  China; Healthcare system reform; Hospital revenue; Public hospitals

Year:  2021        PMID: 34274783     DOI: 10.1016/j.socscimed.2021.114210

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

1.  Impacts of a New Episode-Based Payment Scheme on Volume, Expenditures, and Efficiency in Public Hospitals: A Quasi-Experimental Interrupted Time-Series Study in Jinhua, China.

Authors:  Tao Zhang; Beiyin Lu; Zhongheng Yan; Xiaojun Huang; Wei Lu
Journal:  Risk Manag Healthc Policy       Date:  2022-09-05

2.  Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China.

Authors:  Liming Liu; Yue Xu; Zihan Su; Xiaowei Man; Yan Jiang; Liying Zhao; Wei Cheng
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

3.  The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China.

Authors:  Yuan-Jin Zhang; Yan Ren; Quan Zheng; Jing Tan; Ming-Hong Yao; Yun-Xiang Huang; Xia Zhang; Kang Zou; Shao-Yang Zhao; Xin Sun
Journal:  Front Public Health       Date:  2022-08-12

4.  The impact of comprehensive public hospital reforms on the direct medical cost of inpatients with coronary heart disease.

Authors:  Liming Liu; Yue Xu; Jingfei Yu; Xiaowei Man; Yan Jiang; Liying Zhao; Wei Cheng
Journal:  Front Public Health       Date:  2022-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.